{"disease":{"id":"unstable-angina","name":"Unstable angina","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"fragmin","indication_name":"Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave MI","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"enoxaparin-sodium","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lovenox (Preservative Free)","generic_name":"ENOXAPARIN SODIUM","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Low Molecular Weight Heparin","quality_score":10,"revenue":null,"mechanism":"Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting."},{"drug_id":"heparin","indication_name":"Prevention of Cardiac Ischemia in Unstable Angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"HEPARIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Anti-coagulant","quality_score":56,"revenue":null,"mechanism":"Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots."},{"drug_id":"bivalirudin","indication_name":"Unstable Angina Pectoris during PTCA","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Angiomax","generic_name":"BIVALIRUDIN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"thrombin","drug_class":"Anti-coagulant [EPC]","quality_score":10,"revenue":null,"mechanism":"Bivalirudin directly inhibits thrombin by binding to its catalytic site and anion-binding exosite, preventing thrombus formation."},{"drug_id":"verapamil-hydrochloride","indication_name":"Unstable (crescendo, pre-infarction) angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"fragmin","indication_name":"Prophylaxis of ischemic complications in unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"heparin-sodium","indication_name":"Prevention of Cardiac Ischemia in Unstable Angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"Heparin Sodium","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Antithrombin III, Coagulation Factors Xa and IIa","drug_class":"Anticoagulant","quality_score":63,"revenue":null,"mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa."},{"drug_id":"eptifibatide","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Integrilin","generic_name":"EPTIFIBATIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"Platelet Aggregation Inhibitor [EPC]","quality_score":75,"revenue":null,"mechanism":"Integrilin blocks the binding of fibrinogen to platelets, preventing them from clumping together and forming clots."},{"drug_id":"clopidogrel","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plavix","generic_name":"clopidogrel","company_name":"Generic (originally Sanofi/BMS)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter","drug_class":"Thienopyridine antiplatelet agent","quality_score":55,"revenue":null,"mechanism":"Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis."},{"drug_id":"lovenox","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lovenox","company_name":"University of Monastir","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"enoxaparin","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Enoxaparin","company_name":"Dana-Farber Cancer Institute","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"integrilin","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"integrilin","company_name":"University of Cincinnati","drug_phase":"phase_1","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":12,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04008173","title":"The International Survey of Acute Coronary Syndromes-ARCHIVES","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":130000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT04097912","title":"Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels","phase":"","overall_status":"COMPLETED","enrollment_count":99999,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT01218776","title":"International Survey of Acute Coronary Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":36000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06884436","title":"Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）","phase":"","overall_status":"COMPLETED","enrollment_count":22000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT03421873","title":"Effectiveness and Safety of a Clinical Assessment and 0h/1h Troponin Rule-Out Protocol","phase":"","overall_status":"COMPLETED","enrollment_count":16000,"lead_sponsor_name":"Ulf Ekelund","has_results":false},{"nct_id":"NCT05719545","title":"A Cohort of Patients Undergoing Percutaneous Coronary Intervention","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Su Guohai","has_results":false},{"nct_id":"NCT07471763","title":"Prospective Lifespan Cohort of Myocardial Infarction","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Fujian Provincial Hospital","has_results":false},{"nct_id":"NCT04718025","title":"Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Collegium Medicum w Bydgoszczy","has_results":false},{"nct_id":"NCT04682756","title":"A Multicenter Study on Early Diagnosis of NSTE-ACS Patients Based on Machine Learning Model","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"First Affiliated Hospital of Xinjiang Medical University","has_results":false},{"nct_id":"NCT02601157","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2173,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03363035","title":"Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2055,"lead_sponsor_name":"Second Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03620760","title":"Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2036,"lead_sponsor_name":"Xiaofan Wu","has_results":false},{"nct_id":"NCT06165406","title":"Distal Radial Access for Coronary Procedures","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Hospital Arnau de Vilanova","has_results":false},{"nct_id":"NCT03752515","title":"A Registry Study on Genetics and Biomarkers of Acute Coronary Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Beijing Institute of Heart, Lung and Blood Vessel Diseases","has_results":false},{"nct_id":"NCT03690713","title":"International Collaboration of Comprehensive Physiologic Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":1397,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03338309","title":"INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07444957","title":"Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1118,"lead_sponsor_name":"Fundación Interhospitalaria para la Investigación Cardiovascular FIC","has_results":false},{"nct_id":"NCT05243485","title":"Prehospital Triage of Patients With Suspected Non-ST-segment Elevation Acute Coronary Syndrome: the TRIAGE-ACS Study","phase":"","overall_status":"COMPLETED","enrollment_count":1071,"lead_sponsor_name":"Catharina Ziekenhuis Eindhoven","has_results":false},{"nct_id":"NCT03103620","title":"Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry","phase":"","overall_status":"COMPLETED","enrollment_count":1027,"lead_sponsor_name":"CeloNova BioSciences, Inc.","has_results":false},{"nct_id":"NCT05056662","title":"Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT01881555","title":"Functional Testing Underlying Coronary Revascularisation","phase":"NA","overall_status":"COMPLETED","enrollment_count":941,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04887571","title":"the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry","phase":"","overall_status":"COMPLETED","enrollment_count":870,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT05230446","title":"PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions","phase":"NA","overall_status":"RECRUITING","enrollment_count":609,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04732091","title":"Therapeutic Use of Contrast Ultrasound in Acute Coronary Artery Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06945094","title":"A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":508,"lead_sponsor_name":"Ge Junbo","has_results":false},{"nct_id":"NCT04661709","title":"Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":502,"lead_sponsor_name":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT03084367","title":"Physiologic Assessment of Coronary Stenosis Following PCI","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Volcano Corporation","has_results":true},{"nct_id":"NCT07112547","title":"Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary Syndrome","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT03980990","title":"Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT03700567","title":"Safety and Efficacy of Low Temperature Contrast in UAP Patients During PCI (LOTA-I)","phase":"NA","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT03591328","title":"Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II (EMERALD II) Study","phase":"","overall_status":"UNKNOWN","enrollment_count":429,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04648306","title":"Restore EF Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Abiomed Inc.","has_results":false},{"nct_id":"NCT05409716","title":"Compressive Elastic Dressing Versus TR Band","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"An-Najah National University","has_results":false},{"nct_id":"NCT03935542","title":"Assessment of Diagonal Branch Territory","phase":"","overall_status":"COMPLETED","enrollment_count":355,"lead_sponsor_name":"Bon-Kwon Koo","has_results":false},{"nct_id":"NCT03389503","title":"Comparison of Left and Right Transradial Approach for CAG and PCI","phase":"NA","overall_status":"COMPLETED","enrollment_count":322,"lead_sponsor_name":"Wonju Severance Christian Hospital","has_results":false},{"nct_id":"NCT03037047","title":"Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":320,"lead_sponsor_name":"Green Valley Group of China","has_results":false},{"nct_id":"NCT04861519","title":"Pivotal, Single-arm Clinical Trial to Assess the Efficacy and Safety of the MedHub AutocathFFR Software Device","phase":"","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"Medhub Ltd.","has_results":false},{"nct_id":"NCT03565978","title":"Cardiac Care Solution for Coronary Disease Follow up","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT06436092","title":"Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"TCROSS Co., Ltd.","has_results":false},{"nct_id":"NCT04125992","title":"Distal vs. Forearm Radial Artery Access","phase":"NA","overall_status":"COMPLETED","enrollment_count":212,"lead_sponsor_name":"An-Najah National University","has_results":false},{"nct_id":"NCT06378333","title":"Incidence, Clinical Characteristics and Outcomes of Unstable Angina in the contempoRary Area.","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04683133","title":"The FAST OCT Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04090281","title":"Implementing Precision Medicine Approaches to Guide Anti-platelet Selection","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT05563701","title":"Evaluation of the LVivo Image Quality Scoring (IQS)","phase":"","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"DiA Imaging Analysis Ltd","has_results":false},{"nct_id":"NCT04163484","title":"Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease","phase":"","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT06860997","title":"Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","has_results":false},{"nct_id":"NCT03395041","title":"Periodontal Disease, Inflammation and Acute Coronary Syndromes","phase":"","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Cardio Med Medical Center","has_results":false},{"nct_id":"NCT06183294","title":"Evaluation of a Novel Non-Invasive Automated Fractional Flow Reserve Software System in Patients With Coronary Artery Disease","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT06562309","title":"Fecal Microbiota and Monocyte Trained Immunity in CHD Patients With Different hsCRP","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}